Iain Dukes
@iaindukes2589
Executive Officer, Director
Building Lomond Therapeutics Holdings, Inc. as Executive Officer, Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Lomond Therapeutics Holdings, Inc. was founded in 2021 and has no closure on record.
Named alongside
At Angiex, Inc.
- Amal AminDirector
- Errik AndersonDirector
- Fabian HansenDirector
- Haijing GuoDirector
- Jason CammDirector
- Jonathan AdamsDirector
- Paul JaminetExecutive Officer, Director
- Tina NeelDirector
- Edward MathersDirector
- Keno GutierrezDirector
- Michele CuculluDirector
- Nikolay SavchukExecutive Officer, Director
- David BonitaDirector
- Iain D. DukesDirector
- Jean-Francois D. FormelaDirector
- Jean-Francois FormelaDirector
- Jeffrey EcsedyExecutive Officer
- Jotin MarangoExecutive Officer
- Maria D. KoehlerDirector
- Maria KoehlerDirector
At Lomond Therapeutics Holdings, Inc.
- Carl GordonDirector
- Carl Wang GordonDirector
- Eddie RodriguezDirector
- Eddie Wang RodriguezDirector
- Nikolay SavchukExecutive Officer, Director
At Theseus Pharmaceuticals, Inc.
- Carl C. GordonDirector
- Michael C. RomeDirector
- William C. ShakespeareDirector
Contribution
Iain's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Lomond Therapeutics Holdings, Inc.Pharmaceutical Preparations; formerly Venetian-1 Acquisition Corp.; filing with the SEC since 2021Executive Officer, Director · Pharmaceuticals · DOVER, United States · Founded 2021
- Theseus Pharmaceuticals, Inc.Pharmaceutical Preparations; filing with the SEC since 2018Executive Officer, Director · Pharmaceutical Preparations · NEW YORK, United States · Founded 2017
- Brenig Therapeutics, Inc.Executive Officer, Director · Biotechnology · DOVER, United States · Founded 2021
- Angiex, Inc.Director · Biotechnology · CAMBRIDGE, United States
- Ikena Oncology, Inc.Biological Products, (No Diagnostic Substances); formerly Ikena Oncology, Inc.; listed on Nasdaq as IMA; filing with the SEC since 2021Director · Biotechnology · BOSTON, United States